Form 4 for LNAI Lunai Bioworks Inc.
Accepted 2024-10-29 00:00:00 ET · period of report 2024-10-14 · accession 0001731122-24-001669 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-29 | 2024-10-14 | LNAI | Weinstein David Hershel | CEO, Dir | A - Grant | $0.00 | +250.0K | 250.0K | New | $0 |
| D | 2024-10-29 | 2024-10-14 | LNAI | Weinstein David Hershel | CEO, Dir | A - Grant | $0.00 | +1.60M | 1.60M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-14 | A | A | 250,000 | $0.00 | 250,000 | D | — | — | |
| 2 | Derivative | Option to purchase shares of common stock | 2024-10-14 | A | A | 1,600,000 | $0.00 | 1,600,000 | D | $0.55 · — to 2034-10-14 | 1,600,000 Common stock | (F1) The option vests in eight equal quarterly installments beginning on January 1, 2025. |